SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-22-004817
Filing Date
2022-07-07
Accepted
2022-07-07 07:50:51
Documents
1
Period of Report
2022-07-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT cns_def14a.htm DEF 14A 274606
  Complete submission text file 0001683168-22-004817.txt   275640
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39126 | Film No.: 221070651
SIC: 2834 Pharmaceutical Preparations